title: Nasal azelastine for self-medication: modest symptomatic relief from rhinitis.
abstract: Azelastine nasal solution is another drug to be marketed for allergic rhinitis, backed by a direct-to-consumer advertising campaign, similar to previous promotional campaigns for oral cetirizine and nasal beclometasone. Self-medication with azelastine via the nasal route is acceptable, as it does not seem to provoke serious adverse effects. In contrast, its effectiveness in terms of symptomatic relief from rhinitis is limited.
mesh_terms: D000281:Administration, Intranasal; D018926:Anti-Allergic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010793:Phthalazines / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012651:Self Medication
chemical_list: D018926:Anti-Allergic Agents; D039563:Histamine H1 Antagonists, Non-Sedating; D010793:Phthalazines